EUVIMEDEUVIMED entdecken
Open Access

SMAD2 S-palmitoylation promotes its linker region phosphorylation and T H 17 cell differentiation in a mouse model of multiple sclerosis

Mingming Zhang, Tao Yu iD, Yinong Liu iD, Xuan Lu, Wenzhe Chen iD, Lixing Zhou iD, Yuejie Xu, Min Yang, Andrew D Miller iD, Hening Lin iD

Science Signaling · 2025

DOI: 10.1126/scisignal.adr2008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Mingming Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Howard Hughes Medical Institute, Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA. Hauptthemen laut MEDLINE: Cell Differentiation, Smad2 Protein, Th17 Cells, Lipoylation. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Howard Hughes Medical Institute, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The transcriptional regulators SMAD2 and SMAD3 share the same primary signaling pathway in response to the cytokine TGFβ. However, whereas SMAD2 stimulates the differentiation of naive CD4 + T cells into proinflammatory T helper 17 cells (T H 17 cells), SMAD3 stimulates the differentiation of anti-inflammatory regulatory T cells (T reg cells). Here, we report a dynamic SMAD2-specific posttranslational modification important for T H 17 cell differentiation. SMAD2, but not SMAD3, was reversibly S-palmitoylated at cysteine-41 and cysteine-81 by the palmitoyltransferase DHHC7 and depalmitoylated by the acyl protein thioesterase APT2. As a result, SMAD2 was recruited to intracellular membranes where its linker region was phosphorylated, leading to its interaction with the transcriptional regulator STAT3. Nuclear translocation of the SMAD2-STAT3 complex induced the expression of their target genes that promoted T H 17 cell differentiation. Perturbation of SMAD2-STAT3 binding by inhibiting the palmitoylation-depalmitoylation cycle suppressed T H 17 cell differentiation and reduced disease severity in mice with experimental autoimmune encephalomyelitis, a model of multiple sclerosis (MS). Thus, the S-palmitoylation–depalmitoylation cycle mediated by DHHC7 and APT2 specifically regulates SMAD2, providing insights into the functional differences between SMAD2 and SMAD3 and the distinct role of SMAD2 in T H 17 cell differentiation. The findings further highlight DHHC7 and APT2 as potential therapeutic targets for the treatment of T H 17 cell–mediated inflammatory diseases, including MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell DifferentiationSmad2 ProteinTh17 CellsLipoylationEncephalomyelitis, Autoimmune, ExperimentalMultiple SclerosisAnimalsMicePhosphorylationSTAT3 Transcription FactorDisease Models, AnimalHumansMice, Inbred C57BLAcyltransferasesSignal Transduction

Substanzen

Smad2 ProteinSmad2 protein, mouseSTAT3 Transcription FactorStat3 protein, mouseAcyltransferases

Autor:innen und Institutionen

  • Howard Hughes Medical Institute, Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA.
  • Department of Chemistry and Chemical Biology, Cornell University, Ithaca, NY 14853, USA.
  • Center of Gerontology and Geriatrics/National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Department of Gastroenterology, Drum Tower Hospital Affiliated to Nanjing Medical University, Nanjing 210008, China.
  • Section of Anatomic Pathology, Department of Population Medicine and Diagnostic Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY 14853, USA.
  • Department of Molecular Biology and Genetics, Cornell University, Ithaca, NY 14853, USA.

ORCID-Profile: Tao Yu, Yinong Liu, Wenzhe Chen, Lixing Zhou, Andrew D Miller, Hening Lin

Förderung

  • Howard Hughes Medical Institute
  • NIAID NIH HHS

Zitieren

APA

Zhang, M., Yu, T., Liu, Y., Lu, X., Chen, W., Zhou, L., Xu, Y., Yang, M., Miller, A. D., & Lin, H. (2025). SMAD2 S-palmitoylation promotes its linker region phosphorylation and T H 17 cell differentiation in a mouse model of multiple sclerosis. Science Signaling. https://doi.org/10.1126/scisignal.adr2008

Vancouver

Zhang M, Yu T, Liu Y, Lu X, Chen W, Zhou L, et al. SMAD2 S-palmitoylation promotes its linker region phosphorylation and T H 17 cell differentiation in a mouse model of multiple sclerosis. Science Signaling. 2025. doi:10.1126/scisignal.adr2008

BibTeX
@article{Zhang2025,
  author = {Zhang, Mingming and Yu, Tao and Liu, Yinong and Lu, Xuan and Chen, Wenzhe and Zhou, Lixing and Xu, Yuejie and Yang, Min and Miller, Andrew D and Lin, Hening},
  title = {SMAD2 S-palmitoylation promotes its linker region phosphorylation and T H 17 cell differentiation in a mouse model of multiple sclerosis},
  journal = {Science Signaling},
  year = {2025},
  doi = {10.1126/scisignal.adr2008}
}
Kostenlos starten →